The StartUPDATES is a member feature of MedCitizens, a community of MedCity News startups. Submit here and join.
|InSitu Biologics, an emerging biotech company focusing on the development of AnestaGel™, has received over $2 million in investments. InSitu is believed to be in the midst of the largest Reg A+ round for a pre-revenue biotech company and anticipates investments reaching $10 million in 2019.|
Alto Pharmacy, a San Francisco-based digital pharmacy company, has raised $50 million in a Series C round led by Zola Global and Greenoaks Capital. With the financing, the startup plans to expand to new geographic regions and deliver additional products for chronic and complex therapeutic areas. Additionally, CEO Matt Gamache-Asselin stated that Alto is hiring employees and will keep investing in its physician/pharmacy platform and patient mobile app.
Lumeon, a health tech startup focused on helping healthcare organizations automate systems and processes, has secured $28 million in funding. “With our initial deals deployed and core teams in place, the funding will allow us to grow our business rapidly and take advantage of this critical moment in the healthcare market,” CEO Robbie Hughes said in response to emailed questions.
Xealth, a Seattle-based startup whose platform allows doctors to prescribe digital health content, apps and services, has launched a new ability. Now physicians can use the company’s technology to digitally send patients over-the-counter product recommendations. Xealth, which was spun out of Providence’s Digital Innovation Group, raised $8.5 million in 2017.